Sorrel Medical — raw details

Highlights

1 patent

About

Wearable Drug-delivery Platform

Sorrel Medical develops and manufactures wearable drug-delivery devices designed to optimize the patient experience and the value for pharmaceutical companies. Sorrel's digitally integrated platform is intended for subcutaneous delivery of injectable drugs, biologics, and biosimilars and is suited for multiple configurations, molecules, and indications. The company's partnerships provide core strengths in device R&D, regulation, and manufacturing and leverage experience from the Eitan Group to bring drug-delivery devices to market. Sorrel Medical is part of the Eitan Group.

Identity

Name	Sorrel Medical
Slug	sorrel-medical
Type / kind	startup
Crunchbase ID	sorrel-medical
Source _id	agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoLHN79oKDA

Status

Status	inactive
Status reason	Acquired (Inactive) by LTS Lohmann Therapie-System on Jun 2023 - closed due to acquisition
Last update	2026-05-17

Location

HQ country code	IL
HQ region/district	Center District
HQ city	Netanya
HQ address	Yad Harutsim Street 29, Netanya, Israel

Web & social

LinkedIn	https://www.linkedin.com/company/11293429
Twitter / X	https://twitter.com/SorrelMedical

Classifications

Primary sector Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsPharma & Medical BiotechnologyDrug Delivery

Technologies

Sensing

Target customers

Healthcare & Life SciencesHealthcarePatientsProvidersLife SciencesPharmaceuticals

Business models

B2B

Funding

Total raised	—
Current stage	Acquired

Raw source document

Show full JSON (0 KB)

{
  "0": "s",
  "1": "l",
  "2": "i",
  "3": "m",
  "4": "p",
  "5": "a",
  "6": "g",
  "7": "e",
  "8": "s",
  "9": "_",
  "10": "i",
  "11": "m",
  "12": "p",
  "13": "o",
  "14": "r",
  "15": "t"
}